ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228,276 | -20.4% | 34,173 | 0.0% | 0.06% | -22.1% |
| Q2 2023 | $286,711 | -15.5% | 34,173 | 0.0% | 0.08% | -23.0% |
| Q1 2023 | $339,338 | +42.7% | 34,173 | 0.0% | 0.10% | +28.2% |
| Q4 2022 | $237,844 | +30.7% | 34,173 | 0.0% | 0.08% | +21.9% |
| Q3 2022 | $182,000 | +33.8% | 34,173 | 0.0% | 0.06% | +39.1% |
| Q2 2022 | $136,000 | -10.5% | 34,173 | 0.0% | 0.05% | -11.5% |
| Q1 2022 | $152,000 | -49.3% | 34,173 | 0.0% | 0.05% | -53.6% |
| Q3 2021 | $300,000 | -22.5% | 34,173 | 0.0% | 0.11% | -26.8% |
| Q2 2021 | $387,000 | -4.7% | 34,173 | 0.0% | 0.15% | -11.0% |
| Q1 2021 | $406,000 | +73.5% | 34,173 | 0.0% | 0.17% | +60.7% |
| Q4 2020 | $234,000 | -7.5% | 34,173 | 0.0% | 0.11% | -23.0% |
| Q3 2020 | $253,000 | +76.9% | 34,173 | 0.0% | 0.14% | +65.5% |
| Q2 2020 | $143,000 | +70.2% | 34,173 | 0.0% | 0.08% | +37.7% |
| Q1 2020 | $84,000 | – | 34,173 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |